CHI3L1(YKL40) can regulate immune checkpoint gene expression such as PD-L1, PD-L2, PD-1, LAG3, and TIM3, which may enhance immune suppression in the tumor microenvironment, thus resulting in cancer progression and lymphatic spread. Here, CHI3L1 is linked to neoplasm.